Seeking Alpha

intelligence » Comments » Single Comment |

  • Biotech in Review: Investment Capital for China Biopharma [View article]
    here you go again missing the good news on china pharma receivables
    1. reduced old receivables by more than 50%
    2. sales up 60% while receivables up ONLY half that amount
    3. bad debts not as bad as reservesd for originally

    all good news--and WHY IS THIS A BIOTECH STOCK-NEXT MAYBE INCLUDED IN JUST TECH
    May 05 10:45 am |Rating: 0 0
All Comments by intelligence »
Comments by Ticker
intelligence's
Comments Stats
7 comments
Rating: -1 (0 - 1 is )